Cargando…
Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors
Unprecedented 3D hexa‐adducts of [60]fullerene peripherally decorated with twelve tryptophan (Trp) or tyrosine (Tyr) residues have been synthesized. Studies on the antiviral activity of these novel compounds against HIV and EV71 reveal that they are much more potent against HIV and equally active ag...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361981/ https://www.ncbi.nlm.nih.gov/pubmed/33851758 http://dx.doi.org/10.1002/chem.202101098 |
_version_ | 1783738059667275776 |
---|---|
author | Ruiz‐Santaquiteria, Marta Illescas, Beatriz M. Abdelnabi, Rana Boonen, Arnaud Mills, Alberto Martí‐Marí, Olaia Noppen, Sam Neyts, Johan Schols, Dominique Gago, Federico San‐Félix, Ana Camarasa, María‐José Martín, Nazario |
author_facet | Ruiz‐Santaquiteria, Marta Illescas, Beatriz M. Abdelnabi, Rana Boonen, Arnaud Mills, Alberto Martí‐Marí, Olaia Noppen, Sam Neyts, Johan Schols, Dominique Gago, Federico San‐Félix, Ana Camarasa, María‐José Martín, Nazario |
author_sort | Ruiz‐Santaquiteria, Marta |
collection | PubMed |
description | Unprecedented 3D hexa‐adducts of [60]fullerene peripherally decorated with twelve tryptophan (Trp) or tyrosine (Tyr) residues have been synthesized. Studies on the antiviral activity of these novel compounds against HIV and EV71 reveal that they are much more potent against HIV and equally active against EV71 than the previously described dendrimer prototypes AL‐385 and AL‐463, which possess the same number of Trp/Tyr residues on the periphery but attached to a smaller and more flexible pentaerythritol core. These results demonstrate the relevance of the globular 3D presentation of the peripheral groups (Trp/Tyr) as well as the length of the spacer connecting them to the central core to interact with the viral envelopes, particularly in the case of HIV, and support the hypothesis that [60]fullerene can be an alternative and attractive biocompatible carbon‐based scaffold for this type of highly symmetrical dendrimers. In addition, the functionalized fullerenes here described, which display twelve peripheral negatively charged indole moieties on their globular surface, define a new and versatile class of compounds with a promising potential in biomedical applications. |
format | Online Article Text |
id | pubmed-8361981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83619812021-08-17 Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors Ruiz‐Santaquiteria, Marta Illescas, Beatriz M. Abdelnabi, Rana Boonen, Arnaud Mills, Alberto Martí‐Marí, Olaia Noppen, Sam Neyts, Johan Schols, Dominique Gago, Federico San‐Félix, Ana Camarasa, María‐José Martín, Nazario Chemistry Full Papers Unprecedented 3D hexa‐adducts of [60]fullerene peripherally decorated with twelve tryptophan (Trp) or tyrosine (Tyr) residues have been synthesized. Studies on the antiviral activity of these novel compounds against HIV and EV71 reveal that they are much more potent against HIV and equally active against EV71 than the previously described dendrimer prototypes AL‐385 and AL‐463, which possess the same number of Trp/Tyr residues on the periphery but attached to a smaller and more flexible pentaerythritol core. These results demonstrate the relevance of the globular 3D presentation of the peripheral groups (Trp/Tyr) as well as the length of the spacer connecting them to the central core to interact with the viral envelopes, particularly in the case of HIV, and support the hypothesis that [60]fullerene can be an alternative and attractive biocompatible carbon‐based scaffold for this type of highly symmetrical dendrimers. In addition, the functionalized fullerenes here described, which display twelve peripheral negatively charged indole moieties on their globular surface, define a new and versatile class of compounds with a promising potential in biomedical applications. John Wiley and Sons Inc. 2021-06-01 2021-07-21 /pmc/articles/PMC8361981/ /pubmed/33851758 http://dx.doi.org/10.1002/chem.202101098 Text en © 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full Papers Ruiz‐Santaquiteria, Marta Illescas, Beatriz M. Abdelnabi, Rana Boonen, Arnaud Mills, Alberto Martí‐Marí, Olaia Noppen, Sam Neyts, Johan Schols, Dominique Gago, Federico San‐Félix, Ana Camarasa, María‐José Martín, Nazario Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors |
title | Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors |
title_full | Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors |
title_fullStr | Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors |
title_full_unstemmed | Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors |
title_short | Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors |
title_sort | multivalent tryptophan‐ and tyrosine‐containing [60]fullerene hexa‐adducts as dual hiv and enterovirus a71 entry inhibitors |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361981/ https://www.ncbi.nlm.nih.gov/pubmed/33851758 http://dx.doi.org/10.1002/chem.202101098 |
work_keys_str_mv | AT ruizsantaquiteriamarta multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT illescasbeatrizm multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT abdelnabirana multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT boonenarnaud multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT millsalberto multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT martimariolaia multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT noppensam multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT neytsjohan multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT scholsdominique multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT gagofederico multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT sanfelixana multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT camarasamariajose multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors AT martinnazario multivalenttryptophanandtyrosinecontaining60fullerenehexaadductsasdualhivandenterovirusa71entryinhibitors |